#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16720	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2143	776.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1443	1443	C	958	C	896	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30274	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3732	809.4	0	.	n	.	0	T695C	SNP	695	695	T	1153	1153	C	945	C,T,G	860,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30274	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3732	809.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1795	1795	A	1036	A	956	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30274	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3732	809.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2429	2429	C	985	C,T	907,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30274	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3732	809.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2503	2503	A	927	A,G	865,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30274	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3732	809.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3055	3055	C	986	C	915	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2488	folP	855	855	100.0	folP.l15.c30.ctg.1	1666	148.7	1	SNP	p	R229S	0	.	.	685	687	CGC	1115	1117	CGC	258;252;252	C;G;C	235;230;231	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6644	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3387	195.4	1	SNP	p	S91F	0	.	.	271	273	TCC	616	618	TCC	211;208;208	T;C;C	193;192;189	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6644	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3387	195.4	1	SNP	p	D95N	0	.	.	283	285	GAC	628	630	GAC	213;213;212	G;A;C	197;196;195	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6644	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3387	195.4	1	SNP	p	D95G	0	.	.	283	285	GAC	628	630	GAC	213;213;212	G;A;C	197;196;195	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	2018	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1201	167.0	1	SNP	p	G45D	1	.	.	133	135	GAC	424	426	GAC	284;283;282	G;A;C	262;259;257	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	966	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	968	99.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	6268	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2938	212.3	1	SNP	p	D86N	0	.	.	256	258	GAC	531	533	GAC	269;274;274	G,A;A;C	244,1;246;246	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	6268	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2938	212.3	1	SNP	p	S88P	0	.	.	262	264	TCC	537	539	TCC	276;278;279	T;C;C	251;249;253	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5240	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2723	191.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1620	1622	GGC	294;294;290	G;G;C	268;270;261	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	0	.	p	.	0	P552L	NONSYN	1654	1656	CCG	1912	1914	CTG	180;181;180	C,G;T;G	138,6;135;143	.	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1189	1191	GCA	268;271;270	G;C;A	241;244;243	penA.43.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1192	1194	ATC	265;264;265	A;T;C	240;240;241	penA.43.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1204	1206	GTG	276;273;277	G;T;G	249;244;248	penA.43.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1204	1206	GTG	276;273;277	G;T;G	249;244;248	penA.43.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1708	1710	ACC	238;241;243	A;C;C	216;219;220	penA.43.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1762	1764	GTG	229;223;221	G;T,G;G	202;168,6;198	penA.43.002:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1762	1764	GTG	229;223;221	G;T,G;G	202;168,6;198	penA.43.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1885	1887	GGC	185;184;186	G;G;C	175;171;170	penA.43.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4578	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2452	185.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1894	1896	GGC	178;177;174	G;G;C	165;165;161	penA.43.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6686	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2924	227.2	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1564	1566	CCG	259;256;253	C,T;C;G	226,1;229;225	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2754	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1847	148.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	379	381	GGC	196;194;194	G,A;G;C,A,T	178,1;177;177,1,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2754	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1847	148.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	561	561	C	197	C	178	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3256	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1493	216.8	0	.	p	.	0	G120N	NONSYN	358	360	GGC	646	648	AAC	263;257;258	A;A;C	243;237;241	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3256	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1493	216.8	0	.	p	.	0	E210G	NONSYN	628	630	GAA	916	918	GGA	292;290;290	G;G;A	265;265;266	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3256	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1493	216.8	0	.	p	.	0	Y216_S217del	DEL	646	646	T	934	934	T	297	T	275	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3256	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1493	216.8	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1162	1164	AAT	261;258;257	A;A;T	241;239;241	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3256	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1493	216.8	1	SNP	p	D121N	0	.	.	361	363	GAC	649	651	GAC	258;259;257	G,T;A;C	242,1;241;240	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3256	porB1b	1047	1047	99.04	porB1b.l6.c4.ctg.1	1493	216.8	1	SNP	p	A121D	1	.	.	361	363	GAC	649	651	GAC	258;259;257	G,T;A;C	242,1;241;240	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12180	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4924	246.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1408	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	960	145.6	1	SNP	p	V57M	1	.	.	169	171	ATG	489	491	ATG	283;285;289	A;T;G	265;265;269	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
